Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H10O2 |
Molecular Weight | 162.1852 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C=CCC1=CC=C2OCOC2=C1
InChI
InChIKey=ZMQAAUBTXCXRIC-UHFFFAOYSA-N
InChI=1S/C10H10O2/c1-2-3-8-4-5-9-10(6-8)12-7-11-9/h2,4-6H,1,3,7H2
Molecular Formula | C10H10O2 |
Molecular Weight | 162.1852 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Safrole is a natural product obtained from essential oil of the root bark of Sassafras tree. Safrole has been used as a flavoring agent in drugs and in the manufacture of heliotropin, perfumes, soaps, and piperonyl butoxide. Oil of sassafras, which contains safrole, was formerly used to flavor some soft drinks, such as root beer. However, this use or any other addition of safrole or oil of sassafras to food was banned in the United States in 1960 due to evidence of carcinogenicity. Numerous studies have shown that safrole from betel quid-containing safrole might be involved in the pathogenesis of hepatocellular carcinoma in human due to the formation of DNA adducts. Safrole has also been used in the illicit production of the drug 3,4-methylenedioxymethamphetamine (MDMA, or ecstasy), and the U.S. Drug Enforcement Administration has designated safrole a List I Chemical. Anticancer and anti-diabetic properties of safrole were investigated in vitro and in vivo.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2311221 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18938230 |
|||
Target ID: P05177 Gene ID: 1544.0 Gene Symbol: CYP1A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15778010 |
5.7 µM [IC50] | ||
Target ID: P11509|||Q4VAU1 Gene ID: 1548.0 Gene Symbol: CYP2A6 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15778010 |
12.0 µM [IC50] | ||
Target ID: P05181 Gene ID: 1571.0 Gene Symbol: CYP2E1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15778010 |
1.7 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Catalytic and immunochemical properties of hepatic cytochrome P450 1A in three avian species treated with beta-naphthoflavone or isosafrole. | 2001 Sep |
|
Conservation and diversity of gene families explored using the CODEHOP strategy in higher plants. | 2002 Aug 1 |
|
Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity. | 2002 Dec 15 |
|
Evidence for the involvement of CYP1A2 in the metabolism of bromodichloromethane in rat liver. | 2002 Jul 1 |
|
Effects of safrole on the defensive functions of human neutrophils. | 2003 Apr |
|
In vitro metabolism of fenthion and fenthion sulfoxide by liver preparations of sea bream, goldfish, and rats. | 2003 Feb |
|
Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco. | 2003 Feb |
|
Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation. | 2004 Aug |
|
Age-related differences in susceptibility to carcinogenesis: a quantitative analysis of empirical animal bioassay data. | 2004 Aug |
|
A concise stereocontrolled formal total synthesis of (+/-)-podophyllotoxin using sulfoxide chemistry. | 2004 Jan 21 |
|
Safrole oxide induces apoptosis in A549 human lung cancer cells. | 2004 Sep |
|
The chemical composition of some Lauraceae essential oils and their antifungal activities. | 2004 Sep |
|
Human cytochrome p450 enzyme specificity for bioactivation of safrole to the proximate carcinogen 1'-hydroxysafrole. | 2004 Sep |
|
Expeditious synthesis of bioactive allylphenol constituents of the genus Piper through a metal-free photoallylation procedure. | 2005 Aug 7 |
|
Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. | 2005 Jul 1 |
|
An experimental study of sexual function improving effect of Myristica fragrans Houtt. (nutmeg). | 2005 Jul 20 |
|
Probing the mechanism of sulfoxide-catalyzed hemiacetal activation in dehydrative glycosylation. | 2005 Jul 22 |
|
Assessing susceptibility from early-life exposure to carcinogens. | 2005 Sep |
|
Determination of synthesis method of ecstasy based on the basic impurities. | 2005 Sep 10 |
|
Suppressing Akt phosphorylation and activating Fas by safrole oxide inhibited angiogenesis and induced vascular endothelial cell apoptosis in the presence of fibroblast growth factor-2 and serum. | 2006 |
|
Theory and use of the pseudophase model in gas-liquid chromatographic enantiomeric separations. | 2006 Jan 1 |
|
Illuminating cancer health disparities using ethnogenetic layering (EL) and phenotype segregation network analysis (PSNA). | 2006 Spring |
|
Safrole oxide induces neuronal apoptosis through inhibition of integrin beta4/SOD activity and elevation of ROS/NADPH oxidase activity. | 2007 Feb 20 |
Sample Use Guides
As a food additive, safrole was consumed orally. The addition of safrole to food, however, was banned in 1960.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15778010
The ability of safrole to inhibit cytochromes was investigated using recombinant human P450s expressed in E.Coli. Oxidations were initiated by the addition of a NADPH-generating system containing NADP, glucose-6-phosphate, and glucose-6-phosphate dehydrogenase. Duplicated reactions were carried out at 37 C with shaking for 10–20 min. Stock solution of safrole was prepared using methanol and the final content of methanol was less than 1% in the reaction volume of 0.2–1.0 ml. The same amount of methanol was added in the control reactions.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 17 13:59:38 UTC 2022
by
admin
on
Sat Dec 17 13:59:38 UTC 2022
|
Record UNII |
RSB34337V9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 189.180
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
||
|
JECFA EVALUATION |
SAFROLE AND ISOSAFROLE
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
||
|
NCI_THESAURUS |
C45187
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1607299
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
202-345-4
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
2383532
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
8994
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
CHEMBL242273
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
SAFROLE
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
M9723
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | Merck Index | ||
|
SUB64305
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
D012451
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
RSB34337V9
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
DTXSID0021254
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
94-59-7
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
C44443
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
11831
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
5144
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
RSB34337V9
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY | |||
|
2653
Created by
admin on Sat Dec 17 13:59:38 UTC 2022 , Edited by admin on Sat Dec 17 13:59:38 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
A cinnamon leaf oil of Chinese origin, Cinnamomun japonicum Sieb., contains a high concentration of safrole (60%) and only about 3% eugenol.
|
||
|
PARENT -> CONSTITUENT MAY BE PRESENT |
ASSAY (GC)
|
||
|
PARENT -> CONSTITUENT MAY BE PRESENT |
ASSAY (GC)
|